3D cell culture technique activates normal cell differentiation, morphology, migration, and differentiation. Numerous key players and research industries are rising investment in the 3D cell culture that is likely to fuel the growth of the market in the years to come.
3D cell culture Market: Drivers and Restraints
Some of the factors such as the growing adoption of 3D cell culture in biotech companies, diagnostic centers, pharmaceutical, and hospitals are driving the growth of the 3Dcell culture market during the forecasted period. Increasing demand for regenerative medicine, organ transplantation, and tissue regeneration are some of the other factors that are likely to propel the growth of the market. Increasing awareness for oncological diseases among the patients is expected to fuel the growth of the 3D cell culture market in the near future. Monetary support by non-government and government organizations for cancer research is creating a positive impact on the growth of the global market for 3D cell culture market.
However, stringent process controls for advanced handling capabilities and lack of uniformity in 3D cell culture are the factors that hamper the growth of the market over the predicted period.
3D cell culture Market: Segmental Analysis
The 3D cell culture market is segmented into applications and product type. The product type segment is sub-segmented into Scaffold-free, and Scaffold-based. Based on the application, the market is segmented into Regenerative Medicine, Cancer Research, Drug Discovery, and Stem Cell Research. Cancer Research segment is expected to hold a remarkable market share during the forecasted period.
3D cell culture Market: Regional Outlook
North America is likely to be the largest consumption region over the anticipated period. Europe is expected to hold a significant market share in the near future. Asia Pacific also is expected to capture a significant market share for 3D cell culture during the projected period.
3D cell culture Market: Leading Companies
Nine top players operating into the global market for 3D cell cultural are 3D Biotek, Thermo Fisher Scientific, Reprocell Incorporated, Corning, N3d Bioscience, Lonza Group, Insphero, Kuraray Co, and Merck Kgaa. Thermo Fisher Scientific is expected to be the largest player in the market following by Lonza Group and Corning.
Thermo Fisher Scientific (TMO) Releases Earnings Results, Beats Estimates by $0.06 EPS
Thermo Fisher Scientific has announced its quarterly earnings on January 30, 2019. The company's quarterly earnings per share is $3.25. Thermo Fisher Scientific has earned a revenue of $6.51 billion during the quarter end, compared to the consensus estimate of $6.26 billion. The firm's ROE (Return on Equity) is 16.86% and a net profit is 12.06%. The company's revenue for the quarter end goes up to 7.6% on Y-o-Y basis. The firm has a year high of $253.91 and a year low of $199.85. The company's quick ratio is 1.23, a debt-to-equity ratio is 0.64, and a current ratio is 1.71. The firm's capitalization is $101.54 billion, a beta is 1.14, a PE ratio is 22.61, and a price-to-earnings-growth ratio is 1.65.